Edition:
United Kingdom

TSO3 Inc (TOS.TO)

TOS.TO on Toronto Stock Exchange

0.68CAD
21 Aug 2018
Change (% chg)

$-0.02 (-2.86%)
Prev Close
$0.70
Open
$0.71
Day's High
$0.72
Day's Low
$0.68
Volume
80,953
Avg. Vol
162,151
52-wk High
$2.87
52-wk Low
$0.56

Latest Key Developments (Source: Significant Developments)

TSO3 Reports Qtrly ‍Loss Per Share​ of $0.02
Tuesday, 20 Mar 2018 

March 20 (Reuters) - Tso3 Inc ::TSO3 REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.QTRLY ‍REVENUES INCREASED TO $5.8 MILLION, AS COMPARED TO $5.1 MILLION IN Q3 OF 2017 AND $3.7 MILLION IN Q4 OF 2016​.QTRLY ‍LOSS PER SHARE​ $0.02.  Full Article

TSO3 Provides Duodenoscope Regulatory Filing Update
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - TSO3 Inc ::TSO3 PROVIDES DUODENOSCOPE REGULATORY FILING UPDATE.TSO3 - DIALOGUE WITH U.S. REGULATORS IN CONNECTION WITH REQUEST FOR AI REGARDING CO'S SUBMISSION TO EXTEND CLAIMS OF STERIZONE VP4 STERILIZER.TSO3 SAYS NEXT WRITTEN EXCHANGE WITH U.S. REGULATORS IS PLANNED PRIOR TO END OF YEAR, AFTER WHICH ANOTHER DISCUSSION WILL BE SCHEDULED IN EARLY 2018.  Full Article

TSO3 provides duodenoscope regulatory filing update
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - TSO3 Inc :TSO3 provides duodenoscope regulatory filing update.TSO3-Responded to request for additional information from U.S. FDA; information is in support of submission to extend claims of Sterizone VP4 sterilizer​.  Full Article

TSO3 reports record third quarter 2017 results
Tuesday, 7 Nov 2017 

Nov 6 (Reuters) - TSO3 Inc :TSO3 reports record third quarter 2017 results.TSO3 Inc-qtrly ‍revenue increased to $5.1 million, an 11% sequential increase over $4.6 million recorded in Q2 of 2017​.Qtrly loss per share $0.02‍​.  Full Article

TSO3 provides an update on regulatory activity
Wednesday, 27 Sep 2017 

Sept 27 (Reuters) - Tso3 Inc :TSO3 provides an update on regulatory activity.TSO3 Inc - ‍Co has received correspondence from us regulators pertaining to its submission for extended claims for Sterizone VP4 sterilizer​.TSO3 - Regulators asked to clarify some aspects of proposed labeling consistent with reprocessing of specific duodenoscopes using Sterizone VP4 sterilizer​.TSO3 Inc - ‍Regulators asked for specific testing to be documented pertaining to what they describe as "challenge features" of identified devices​.TSO3 Inc - ‍Company is preparing a notice for regulators addressing specific questions, as well as outline intended actions for their comment​.TSO3 Inc - ‍Company's goal is to provide a complete and final response within 180-day limit established by regulators​.  Full Article

TSO3 provides an update on recent activities
Thursday, 7 Sep 2017 

Sept 7 (Reuters) - TSO3 Inc :TSO3 provides an update on recent activities.TSO3 Inc - ‍a hospital in Canada has initiated terminal sterilization of duodenoscopes with company's Sterizone VP4 Sterilizer​.  Full Article

TSO3 files for an extended claim for duodenoscopes
Thursday, 20 Jul 2017 

July 20 (Reuters) - TSO3 Inc ::TSO3 files for an extended claim for duodenoscopes.Has filed a 510(k) submission with US regulators for its STERIZONE VP4 Sterilizer.Filing supported by lab data validating STERIZONE VP4 Sterilizer can terminally sterilize multi-channel flexible endoscopes with a duodenovideoscope.  Full Article

TSO3 expands duodenoscope regulatory filing strategy
Wednesday, 14 Jun 2017 

June 14 (Reuters) - TSO3 Inc :TSO3 expands duodenoscope regulatory filing strategy.TSO3 Inc says now plans to seek 510(k) clearance for its sterizone VP4 sterilizer from U.S. regulators.Company's goal is to receive us clearance forolympus tjf-Q180V and Pentax ED-3490TK duodenoscopes by end of 2017.TSO3 Inc says seeking clearance for terminal sterilization of two duodenoscopes used in majority of ERCP procedures performed globally.TSO3 Inc- Mark Pasmore, vice president research and development, has resigned due to personal reasons.  Full Article

TSO3 reports Q1 loss per share $0.02
Wednesday, 10 May 2017 

May 10 (Reuters) - TSO3 Inc : :TSO3 reports record first quarter 2017 results.TSO3 inc qtrly revenue increased to a record $4.2 million, a 13.5pct sequential increase over $3.7 million recorded in Q4 of 2016.Q1 loss per share $0.02.Q1 earnings per share view $-0.01, revenue view $4.1 million -- Thomson Reuters I/B/E/S.  Full Article

TSO3 qtrly loss per share $0.02
Tuesday, 21 Mar 2017 

TSO3 Inc : TSO3 reports record fourth quarter and full year 2016 results . Qtrly revenue increased to $3.75 million compared to $0.15 million in same period last year . TSO3 Inc qtrly loss per share $0.02 . Q4 earnings per share view $-0.01, revenue view $2.8 million -- Thomson Reuters I/B/E/S .TSO3 Inc - "2017 will also see us expand upon use of our existing laboratories in Québec and South Carolina".  Full Article

BRIEF-TSO(3) Receives Clearance From U.S. Regulators For The STERIZONE VP4 Sterilizer

* RECEIVED CLEARANCE FROM U.S. REGULATORS FOR MOST RECENT 510(K) SUBMISSION FOR COMPANY'S STERIZONE VP4 STERILIZER